Naeglearia fowleri proline tRNA synthetase inhibitors
福氏耐格里霉脯氨酸 tRNA 合成酶抑制剂
基本信息
- 批准号:10691134
- 负责人:
- 金额:$ 14.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Amino Acyl-tRNA SynthetasesAmoeba genusBrainChemicalsClinicalCollectionCommunicable DiseasesDrug TargetingEatingFresh WaterHot SpringsInfectionMachine LearningMicroscopicModelingNaegleria fowleriNational Center for Advancing Translational SciencesPathogenicityProtozoaQuantitative Structure-Activity RelationshipRiversSamplingSoilWorkchemical propertyhigh throughput screeningin silicoinhibitorknowledge baseprimary amebic meningoencephalitisproline-tRNAscreeningsmall molecule librariesvirtual screening
项目摘要
Proline tRNA synthetase inhibitors discovered to date have all been knowledge-based and sampled an extremely small portion of chemical property space and compounds identified this way have had negligible clinical impact against infectious diseases. During this period, the project team conducted quantitative high-throughput screening (qHTS) on select small molecule libraries, and hit compounds were validated.
Machine learning approaches were utilized to construct in silico quantitative structure-activity relationship (QSAR) models to enable virtual screening of compounds against larger collections of NCATS molecules. Work is ongoing screening larger compound collections to identify compounds with increased potency and enable refinement of the QSAR model.
到目前为止,发现的脯氨酸tRNA合成酶抑制剂都是基于知识的,采样的化学性质空间非常小,这种方法鉴定的化合物对感染性疾病的临床影响可以忽略不计。在此期间,项目组对选定的小分子文库进行了定量高通量筛选(QHTS),并对HIT化合物进行了验证。
机器学习方法被用来构建电子定量结构-活性关系(QSAR)模型,以实现针对更大的NCATS分子集合的化合物的虚拟筛选。正在进行的工作是筛选更大的化合物集合,以识别具有更高效力的化合物,并使QSAR模型能够得到完善。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexey Zakharov其他文献
Alexey Zakharov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexey Zakharov', 18)}}的其他基金
Screening for small molecule inhibitors of B. burgdorferi HtrA
伯氏疏螺旋体HtrA小分子抑制剂的筛选
- 批准号:
10919702 - 财政年份:
- 资助金额:
$ 14.62万 - 项目类别:
Screening for small molecule inhibitors of B. burgdorferi HtrA
伯氏疏螺旋体HtrA小分子抑制剂的筛选
- 批准号:
10691142 - 财政年份:
- 资助金额:
$ 14.62万 - 项目类别:
Improving 15-LOX-2 small molecule inhibitors through medicinal chemistry and structure-guided design
通过药物化学和结构引导设计改进 15-LOX-2 小分子抑制剂
- 批准号:
10919696 - 财政年份:
- 资助金额:
$ 14.62万 - 项目类别:
Improving 15-LOX-2 small molecule inhibitors through medicinal chemistry and structure-guided design
通过药物化学和结构引导设计改进 15-LOX-2 小分子抑制剂
- 批准号:
10691131 - 财政年份:
- 资助金额:
$ 14.62万 - 项目类别:














{{item.name}}会员




